Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 1st Avenue
Suite 5E
New York, NY 10016Phone+1 212-481-1350
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
- Harvard Medical SchoolClass of 1975
- Massachusetts Institute of TechnologyB.S., 1971
Certifications & Licensure
- NY State Medical License 1976 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Member Association of American Physicians, 1999
- Merck Frost Visiting Professor McGill University, 2009
- Richard Lewar Centre of Excellence in Cardiovascular Research, Distinguished Visiting Professor University of Toronto, 2009
- Join now to see all
Publications & Presentations
PubMed
- 429 citationsHyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.Prabhakara R Nagareddy, Andrew J. Murphy, Roslynn A. Stirzaker, Yunying Hu, Shiquing Yu
Cell Metabolism. 2013-05-07 - 44 citationsSGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr−/− type 1 diabetic miceAnnas Al-Sharea, Andrew J. Murphy, L.A. Huggins, Yunying Hu, Ira J. Goldberg
Atherosclerosis. 2018-03-02 - 969 citationsDefective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis developmentHyun Mi Kang, Seon Ho Ahn, Peter S. Choi, Yi-An Ko, Seung Hyeok Han
Nature Medicine. 2015-01-01
Journal Articles
- Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?Heinecke JW, Goldberg IJ, Diabetes, 1/1/2014
- Cardiac Metabolic Compensation to Hypertension Requires Lipoprotein LipaseYamashita H, KG. Bharadwaj, S Ikeda, T-S Park, IJ Goldberg, A J Physio, Endo/Metab, 1/1/2008
- In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatationTakahashi M, M Yokoyama, Y Hiyama, Y Hu, K Melford, A Bensadoun, IJ Goldberg, ATVB, 1/1/2008
- Join now to see all
Books/Book Chapters
Lectures
- Diabetes and Hypertriglyceridemia: Cardiovascular Risk, Mechanisms, and Indications for TreatmentENDO 2019 - New Orleans, LA - 3/26/2019
- Hepatic Substrate Metabolism and Cardiometabolic DiseaseENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
- Endocrinology Board Review, Endocrinology SocietySan Francisco - 9/2/2014
- Join now to see all
Press Mentions
- Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3November 4th, 2020
- Adults with Endocrine Disorders Have an Increased Risk of Heart DiseaseOctober 23rd, 2020
- 'Stench of Death' Compound Helps Your Body Feast on Its Own Rotting CellsJanuary 31st, 2020
- Join now to see all
Grant Support
- Diabetes-Mediated Effects On Myeloid Precursors And Vascular ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2012
- Nutritional And Hormonal Pathways For Reduction Of Apob-LipoproteinsNational Heart, Lung, And Blood Institute2012
- Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2010–2011
- Hyperglycemia, Aldose Reductase And Murine AtherosclerosisNational Heart, Lung, And Blood Institute2006–2010
- Creating Glucose Responsive Cardiovascular ComplicationsNational Heart, Lung, And Blood Institute2006–2010
- Mechanisms Of Fatty Acid Uptake By Cardiac MuscleNational Heart, Lung, And Blood Institute2003–2010
- Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2000–2009
- Role Of Leptin In Atherosclerosis And Arterial InjuryNational Heart, Lung, And Blood Institute2006–2007
- Vascular Effects Of Heparan Sulfate ProteoglycansNational Heart, Lung, And Blood Institute2002–2006
- Hyperglycemia, Aldose Reducatse &Murine AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Atherogenicity Of APOB Containing LipoproteinsNational Heart, Lung, And Blood Institute1999–2003
- Lipolysis, Lipoprotein Lipase And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
- Extracellular Regulation Of Lipoprotein LipaseNational Heart, Lung, And Blood Institute1995–1999
- Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute1991–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: